NO982942L - Blood compatible and bactericidal block copolymer - Google Patents

Blood compatible and bactericidal block copolymer

Info

Publication number
NO982942L
NO982942L NO982942A NO982942A NO982942L NO 982942 L NO982942 L NO 982942L NO 982942 A NO982942 A NO 982942A NO 982942 A NO982942 A NO 982942A NO 982942 L NO982942 L NO 982942L
Authority
NO
Norway
Prior art keywords
block copolymer
carboxylic acid
relates
bactericidal
polyurethane
Prior art date
Application number
NO982942A
Other languages
Norwegian (no)
Other versions
NO982942D0 (en
Inventor
Christine Anders
G Nter Lorenz
Original Assignee
H Ls Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Ls Ag filed Critical H Ls Ag
Publication of NO982942D0 publication Critical patent/NO982942D0/en
Publication of NO982942L publication Critical patent/NO982942L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • C08G81/024—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G
    • C08G81/027—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G containing polyester or polycarbonate sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/62—Polymers of compounds having carbon-to-carbon double bonds
    • C08G18/6287—Polymers of sulfur containing compounds having carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • C08G81/024—Block or graft polymers containing sequences of polymers of C08C or C08F and of polymers of C08G

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Paints Or Removers (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Coating Of Shaped Articles Made Of Macromolecular Substances (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)

Abstract

Oppfinnelsen angår en blokkopolymer, innehold- ende sulfonat- og karboksylsyregrupperbærende blokker A og polyuretan- eller polyesterblokker B, samt forbindelser av disse blokkopolymerer og en ytterligere polymer. Oppfinnelsen angår videre en fremgangsmåte til fremstilling av blokkopolymerer, ved det at en kopolymer C, som inneholder hydroksylgrupper og/eller aminogrupper samt minst en sulfonatgruppeinneholdende monomer (a) og minst en karboksylsyregruppeinneholdende monomer (b), omsettes med en polyuretan D med enestående isocyanatgrupper eller en polyester D med endestående karboksylsyrekloridgrupper. Oppfinnelsen angår også produkter, som helt eller delvis er blitt belagt med en slik blokkopolymer eller består helt eller delvis av en slik forbindelse, til medisinske, hygieniske, tekniske, næringsmiddel- eller biotekniske formål.The invention relates to a block copolymer containing sulfonate and carboxylic acid grouping blocks A and polyurethane or polyester blocks B, as well as compounds of these block copolymers and a further polymer. The invention further relates to a process for the preparation of block copolymers in which a copolymer C containing hydroxyl groups and / or amino groups and at least one sulfonate group-containing monomer (a) and at least one carboxylic acid group-containing monomer (b) is reacted with a polyurethane D with unique isocyanate a polyester D with terminal carboxylic acid chloride groups. The invention also relates to products which have been wholly or partially coated with such a block copolymer or consist wholly or partially of such a compound, for medical, hygienic, technical, food or biotechnological purposes.

NO982942A 1997-06-24 1998-06-24 Blood compatible and bactericidal block copolymer NO982942L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1997126735 DE19726735A1 (en) 1997-06-24 1997-06-24 Blood-compatible and bacteria-repellent block copolymer

Publications (2)

Publication Number Publication Date
NO982942D0 NO982942D0 (en) 1998-06-24
NO982942L true NO982942L (en) 1998-12-28

Family

ID=7833462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982942A NO982942L (en) 1997-06-24 1998-06-24 Blood compatible and bactericidal block copolymer

Country Status (5)

Country Link
EP (1) EP0887368A1 (en)
JP (1) JPH11100429A (en)
CA (1) CA2241381A1 (en)
DE (1) DE19726735A1 (en)
NO (1) NO982942L (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105198B2 (en) * 2002-01-14 2006-09-12 Medtronic Vascular, Inc. Method for coating stent
US20030225451A1 (en) * 2002-01-14 2003-12-04 Rangarajan Sundar Stent delivery system, device, and method for coating
US8680362B2 (en) * 2010-06-28 2014-03-25 The Procter & Gamble Company Substrate coated with a hydrophilic elastomer
US8409664B2 (en) 2010-06-28 2013-04-02 The Procter & Gamble Company Superabsorbent polymer particles coated with a hydrophilic elastomer and absorbent article comprising such particles
US20230225319A1 (en) * 2020-04-17 2023-07-20 Kraton Polymers Llc Antimicrobial Spray Composition
WO2021212147A2 (en) * 2020-04-17 2021-10-21 Kraton Polymers Llc Bio-secure protective equipment and methods for making

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0639495B2 (en) * 1989-07-31 1994-05-25 東洋製罐株式会社 Process for producing antibacterial polymer and use thereof

Also Published As

Publication number Publication date
JPH11100429A (en) 1999-04-13
DE19726735A1 (en) 1999-01-07
CA2241381A1 (en) 1998-12-24
NO982942D0 (en) 1998-06-24
EP0887368A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
IL209190A (en) Polypeptides having a specific amino acid sequence and a method of determining the average molecular weight of the glatiramer acetate
NO931809L (en) hemophilia
CA2449244A1 (en) Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
BR9710452A (en) Anïïlogos of exendin processes for its preparation and medicines containing the same
AU5062099A (en) An antilipemic formulation
BR0009505A (en) Lung cancer therapy and diagnosis compounds and processes
NO991130L (en) Modified amino acids, pharmaceutical preparations containing these compounds and processes for their preparation
EP1120428A3 (en) Water-swellable polymer gel and process for preparing the same
DE69802389D1 (en) CONNECTIONS USED AS EFFECTORS OF NEUROEXCITATORY AMINO ACID SENSITIVE RECEPTORS OF THE CENTRAL VENEER SYSTEM, THEIR PRODUCTION AND THEIR BIOLOGICAL USE
DK0784703T3 (en) Laminin Chains: Diagnostic and Therapeutic Use
GB9925056D0 (en) Preparation of biologically-active molecules by template polymerization
NO881670L (en) DIAGNOSTIC TEST FOR PLASMINOGEN ACTIVATOR INHIBITOR OF TISSUE AND UROKINAS TYPE, AND GENES CODING FOR THE INHIBITOR.
NO882510L (en) SUSPENSION POLYMERIZATION PROCESS FOR THE PREPARATION OF ADHESIVE ELASTOMER POLYMERIC MICROSPHERES AND APPLICATION OF THESE IN AN ADHESIVE AGENT.
NO982942L (en) Blood compatible and bactericidal block copolymer
CA2153756A1 (en) Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use
ID23504A (en) PHARMACY COMPOSIONS CONTAINING VITAMIN D AND CALCIUM, THE MAKING AND USE OF THERAPY
DE69334146D1 (en) PEPTIDES WITH GDP-EXCHANGE FACTORY ACTIVITY, NUCLEIC ACID SEQUENCES THAT ARE CODED FOR, THEIR PREPARATION AND USE
NO880179D0 (en) POLYMER COMPLEXES, PROCEDURE FOR THE PREPARATION OF THESE, AND PHARMACEUTICAL AGENTS CONTAINING THESE.
IL95391A0 (en) Substituted n-(quinolin-2-yl-methoxy)benzyl-sulphonyl-ureas,their preparation and pharmaceutical compositions containing them
FI960369A (en) Base substituted benzoylguanidines, process for their preparation, use thereof as a medicament or as a diagnostic agent and as a medicament containing them
WO2003007733A8 (en) Protein-containing foodstuff comprising a cross-linking enzyme and a hydrocolloid
CA2228559A1 (en) Aqueous crosslinking polymer dispersions and their use for the preparation of water-based adhesives
WO1994026903A3 (en) Human influenza virus peptides binding hla-i molecule
WO1999008667A3 (en) Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
CA2269077A1 (en) Keratinocyte growth factor-2 products

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application